Pelage Pharmaceuticals
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
907 Westwood Blvd Pmb 384, Los Angeles, ...Website
www.pelagepharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Pelage Pharmaceuticals
Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing novel treatments for hair loss including androgenetic alopecia and chemotherapy-induced-alopecia. With a focus on molecular and stem cell biology, Pelage is advancing a new class of treatments designed to reactivate dormant hair follicle stem cells and restore the body's ability to naturally grow hair. Its lead program, PP405, is currently in clinical trials. Through its rigorous scientific foundation, topical formulation, and novel mechanism of action, Pelage is pioneering first-in-class hair growth solutions for people of all hair types experiencing hair loss.Explore more
Pelage Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pelage Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Pelage Pharmaceuticals had a recent Job posting/layoffs
Check out if Pelage Pharmaceuticals is spiking on competitors!
Pelage Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Pelage Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Pelage Pharmaceuticals launches new products
Earning: See what the market has to say on Pelage Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Pelage Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Pelage Pharmaceuticals
Recommended Actions
Reach out to Masked Content who joined Pelage Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Pelage Pharmaceuticals
Compare insights from companies similar to Pelage Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pelage Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pelage Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pelage Pharmaceuticals.
Pelage Pharmaceuticals financials insights
Gather financial insights about Pelage Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$30.8M
2025
Series B
$120M
Pelage Pharmaceuticals Tech Stack
A closer look at the technologies used by Pelage Pharmaceuticals
See more technologies
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Promotion
Executive Move
Executive Moves, Promotion
Promotion
Executive Move
Executive Moves, Promotion
Person-Based
Person-Based
Pelage Pharmaceuticals News & Media
Pelage Pharmaceuticals Raises $120M Series B for Hair Loss Treatment
Los Angeles biotech firm Pelage Pharmaceuticals raises a $120 million Series B round co-led by ARCH Venture Partners and Google Ventures to advance PP405, its potential first-in-class topical treatment for hair loss.Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance ...
LOS ANGELES, October 15, 2025--Pelage Pharmaceuticals, a clinical-stage regenerative medicine biotechnology company, today announced the close of a $120 million Series B financing co-led by ARCH Venture Partners and GV (Google Ventures), with participation from existing investors including Main Street Advisors, Visionary Ventures, and YK Bioventures. The financing will support the continued advancement of Pelage’s lead program, PP405, a topical small molecule designed to reactivate dormant hairPelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy
LOS ANGELES--(BUSINESS WIRE)-- #HairLoss--Pelage’s PP405, a first-in-class regenerative treatment, reactivates dormant stem cells to regrow hair. Phase 2a shows early, significant results.Pelage Pharmaceutical Raises $14M Series A-1 Funding
Pelage Pharmaceutical, a Los Angeles, CA-based clinical-stage regenerative medicine company focused on hair loss, raised $14M in Series A-1 funding. The round was led by GV. The company intends to use the funds to accelerate its Phase 2 clinical program. Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing novel treatments for hair loss including […] The post Pelage Pharmaceutical Raises $14M Series A-1 Funding appeared first on FinSMEs.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Pelage Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing novel treatments for hair loss including androgenetic alopecia and chemotherapy-induced-alopecia. With a focus on molecular and stem cell biology, Pelage is advancing a new class of treatments designed to reactivate dormant hair follicle stem cells and restore the b... Read More
